MYCN and neoplasm: Current risk classification utilizes clinical factors at diagnosis (age (5), disease stage (5–7) and tumor biologic features (MYCN status (8), DNA ploidy status (9, 10), and histopathology (11) to assign patients to appropriate therapy based on risk of treatment failure.